Home
About
Overview
Sharing Data
ORCID
Help
History (481)
A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand.
Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number.
Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.
See All 481 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.
Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets. Proc Natl Acad Sci U S A. 1985 Nov; 82(21):7434-8.
View in:
PubMed
subject areas
Blood Platelets
Cell Fractionation
Cholic Acids
Chromatography, Gel
Humans
Receptors, Cell Surface
Receptors, Prostaglandin
Receptors, Thromboxane
Receptors, Thromboxane A2, Prostaglandin H2
Solubility
Thromboxane A2
authors with profiles
Perry V. Halushka